ACS Omega · 2019 · 41 citations · 55 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryOral Drug DeliveryPharmaceutical FormulationDrug Delivery BiomaterialsDrug Delivery EngineeringDrug Delivery SystemsDrug EncapsulationNanocarriers For TherapeuticsOral NanocarriersActivated CarbonDrug Delivery NanocarriersDrug Stability EnhancementFunctional Species GroupsMetal-organic Framework SynthesisMetal-organic FrameworksPh DependencePorous Biomaterial Carriers
≈ 0.98) for up to 10 days, which would be very effective in IBU dosing to the human body. Moreover, the release rate could be controlled by changing the pH of the releasing solution. The rate of IBU release from both pristine and modified Zr-DASDCAs at pH 7.4 and 3.0 was also explained with a few interactions such as H-bonding and electrostatic repulsion, together with the relative pore size of the Zr-DASDCAs. Therefore, the results suggested that functionalization of MOFs via postsynthetic modification, especially with OC and TC, to introduce various functional groups onto MOFs is an effective approach to not only reducing the release rate of IBU but also inducing a constant release of IBU for as long as 10 days.
55
Metal–Organic Frameworks as Platforms for Functional Materials
Yuanjing Cui, Bin Li, Huajun He et al. · Accounts of Chemical Research · 2016 · 1.7K citations